| GC46410-50μg |
|
— |
11β-13,14-dihydro-15-keto Prostaglandin F2α-d4
|
0 |
C20H30D4O5 |
|
|
|
| GC46409-1mg |
|
— |
|
0 |
C19H23D3O3 |
|
|
|
| GC46408-500μg |
|
1240398-15-5 |
11-dehydro Thromboxane B2-d4
|
0 |
C20H28D4O6 |
|
|
|
| GC46408-100μg |
|
1240398-15-5 |
11-dehydro Thromboxane B2-d4
|
0 |
C20H28D4O6 |
|
|
|
| GC46408-50μg |
|
1240398-15-5 |
11-dehydro Thromboxane B2-d4
|
0 |
C20H28D4O6 |
|
|
|
| GC46408-25μg |
|
1240398-15-5 |
11-dehydro Thromboxane B2-d4
|
0 |
C20H28D4O6 |
|
|
|
| GC46407-10mg |
|
— |
1-1(Z)-Hexadecenyl-2-Palmitoyl-d9-sn-glycero-3-PE
|
0 |
C37H65D9NO7P |
|
|
|
| GC46407-5mg |
|
— |
1-1(Z)-Hexadecenyl-2-Palmitoyl-d9-sn-glycero-3-PE
|
0 |
C37H65D9NO7P |
|
|
|
| GC46407-1mg |
|
— |
1-1(Z)-Hexadecenyl-2-Palmitoyl-d9-sn-glycero-3-PE
|
0 |
C37H65D9NO7P |
|
|
|
| GC46406-5mg |
|
162758-92-1 |
11(Z),14(Z)-Eicosadienoic Acid Ethanolamide
|
0 |
C22H41NO2 |
|
|
|
| GC46406-1mg |
|
162758-92-1 |
11(Z),14(Z)-Eicosadienoic Acid Ethanolamide
|
0 |
C22H41NO2 |
|
|
|
| GC46406-500μg |
|
162758-92-1 |
11(Z),14(Z)-Eicosadienoic Acid Ethanolamide
|
0 |
C22H41NO2 |
|
|
|
| GC46405-1mg |
|
— |
|
0 |
C34H35D31O4 |
|
|
|
| GC46405-500μg |
|
— |
|
0 |
C34H35D31O4 |
|
|
|
| GC46405-250μg |
|
— |
|
0 |
C34H35D31O4 |
|
|
|
| GC46405-100μg |
|
— |
|
0 |
C34H35D31O4 |
|
|
|
| GC46404-1mg |
|
618104-32-8 |
|
0 |
C12H14O5 |
|
|
|
| GC46403-1mg |
|
— |
|
0 |
C18H16D17NO4 |
|
|
|
| GC46403-500μg |
|
— |
|
0 |
C18H16D17NO4 |
|
|
|
| GC46403-100μg |
|
— |
|
0 |
C18H16D17NO4 |
|
|
|
